Huntsville, AL · Founded 2009 · Privately Held (backing)
Developer of a medical diagnostic device designed to detect and identify pathogens and to bring infection detection to the point of care. GeneCapture is based in Huntsville, AL and was founded in 2009. Its last reported valuation was $23.5 million in Sep 2021. It has raised $7.4 million across 2 recorded rounds; the latest was a $500,000 seed round in Nov 2024.
Last reported valuation
$23.5M
Oct 2026
Priced at
—
Total raised
$7.4M
Last round
Seed Round
Nov 2024
No prints on record
No secondary trades in GeneCapture shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GeneCapture with a free account
·The complete investor list: 11 names
·Watch GeneCapture: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of GeneCapture stock.
